Segment disclosures

Company overview

쎌바이오텍

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 49 retained observations 33 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3015814220703 KRW20260814Open filing evidence
2026-01-01 – 2026-06-3030411509397 KRW20260814Open filing evidence
2026-01-01 – 2026-03-3114597288694 KRW20260515Open filing evidence
2025-01-01 – 2025-12-3153125673480 KRW20260318Open filing evidence
2025-07-01 – 2025-09-3015355185982 KRW20251114Open filing evidence
2025-01-01 – 2025-09-3038493847493 KRW20251114Open filing evidence
2025-04-01 – 2025-06-3011909770622 KRW20260814Open filing evidence
2025-01-01 – 2025-06-3023138661511 KRW20260814Open filing evidence
2025-01-01 – 2025-03-3111228890889 KRW20260515Open filing evidence
2024-01-01 – 2024-12-3149912668669 KRW20260318Open filing evidence
2024-07-01 – 2024-09-3012162252595 KRW20251114Open filing evidence
2024-01-01 – 2024-09-3037757662918 KRW20251114Open filing evidence
2024-04-01 – 2024-06-3012557619109 KRW20250814Open filing evidence
2024-01-01 – 2024-06-3025595410323 KRW20250814Open filing evidence
2024-01-01 – 2024-03-3113037791214 KRW20250515Open filing evidence
2023-01-01 – 2023-12-3153787388529 KRW20260318Open filing evidence
2023-07-01 – 2023-09-3013659840066 KRW20241114Open filing evidence
2023-01-01 – 2023-09-3038945233457 KRW20241114Open filing evidence
2023-04-01 – 2023-06-3012440579292 KRW20240814Open filing evidence
2023-01-01 – 2023-06-3025285393391 KRW20240814Open filing evidence
2023-01-01 – 2023-03-3112844814099 KRW20240516Open filing evidence
2022-01-01 – 2022-12-3150525748850 KRW20250725Open filing evidence
2022-07-01 – 2022-09-3012417878129 KRW20231114Open filing evidence
2022-01-01 – 2022-09-3036720240717 KRW20231114Open filing evidence
2022-04-01 – 2022-06-3012203324175 KRW20230814Open filing evidence
2022-01-01 – 2022-06-3024302362588 KRW20230814Open filing evidence
2022-01-01 – 2022-03-3112099038413 KRW20230515Open filing evidence
2021-01-01 – 2021-12-3146873312425 KRW20240319Open filing evidence
2021-07-01 – 2021-09-3012745704373 KRW20221114Open filing evidence
2021-01-01 – 2021-09-3034839893064 KRW20221114Open filing evidence
2021-04-01 – 2021-06-3011450065606 KRW20220816Open filing evidence
2021-01-01 – 2021-06-3022094188691 KRW20220816Open filing evidence
2021-01-01 – 2021-03-3110644123085 KRW20220516Open filing evidence
2020-01-01 – 2020-12-3145582255759 KRW20230315Open filing evidence
2020-07-01 – 2020-09-3011181151046 KRW20211115Open filing evidence
2020-01-01 – 2020-09-3034661618037 KRW20211115Open filing evidence
2020-04-01 – 2020-06-3011409756405 KRW20210817Open filing evidence
2020-01-01 – 2020-06-3023480466991 KRW20210817Open filing evidence
2020-01-01 – 2020-03-3112070710586 KRW20210517Open filing evidence
2019-01-01 – 2019-12-3145959677976 KRW20220322Open filing evidence
2019-07-01 – 2019-09-3010524495953 KRW20201116Open filing evidence
2019-01-01 – 2019-09-3033631290290 KRW20201116Open filing evidence
2019-04-01 – 2019-06-3011658205700 KRW20200814Open filing evidence
2019-01-01 – 2019-06-3023106794337 KRW20200814Open filing evidence
2019-01-01 – 2019-03-3111448588637 KRW20200515Open filing evidence
2018-01-01 – 2018-12-3162543665262 KRW20210317Open filing evidence
2018-07-01 – 2018-09-3014651624219 KRW20191114Open filing evidence
2018-01-01 – 2018-09-3046829251204 KRW20191114Open filing evidence
2017-01-01 – 2017-12-3161056741253 KRW20200330Open filing evidence